These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24574796)

  • 1. Therapy with stem cells in inflammatory bowel disease.
    Martínez-Montiel Mdel P; Gómez-Gómez GJ; Flores AI
    World J Gastroenterol; 2014 Feb; 20(5):1211-27. PubMed ID: 24574796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.
    Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
    Kirsner JB
    Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.
    Yamada A; Arakaki R; Saito M; Tsunematsu T; Kudo Y; Ishimaru N
    World J Gastroenterol; 2016 Feb; 22(7):2195-205. PubMed ID: 26900284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease. Part I: Nature and pathogenesis.
    Kirsner JB
    Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators.
    Pockley AG; Lindsay JO; Foulds GA; Rutella S; Gribben JG; Alexander T; Snowden JA
    Front Immunol; 2018; 9():646. PubMed ID: 29670622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Dave M; Mehta K; Luther J; Baruah A; Dietz AB; Faubion WA
    Inflamm Bowel Dis; 2015 Nov; 21(11):2696-707. PubMed ID: 26230863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
    Adak S; Mukherjee S; Sen D
    Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
    Hawkey CJ; Hommes DW
    Gastroenterology; 2017 Feb; 152(2):389-397.e2. PubMed ID: 27845055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
    Ko JZ; Johnson S; Dave M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects and pathophysiology of inflammatory bowel disease.
    Hendrickson BA; Gokhale R; Cho JH
    Clin Microbiol Rev; 2002 Jan; 15(1):79-94. PubMed ID: 11781268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease.
    Knigge KL
    Clin Cornerstone; 2002; 4(4):49-60. PubMed ID: 12739326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
    Liu Y; Wang X; Hu CA
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease.
    Jauregui-Amezaga A; Rovira M; Marín P; Salas A; Pinó-Donnay S; Feu F; Elizalde JI; Fernández-Avilés F; Martínez C; Gutiérrez G; Rosiñol L; Carreras E; Urbano A; Lozano M; Cid J; Suárez-Lledó M; Mensa J; Rimola J; Rodríguez S; Masamunt MC; Comas D; Ruíz I; Ramírez-Morros A; Gallego M; Ordás I; Panés J; Ricart E
    Gut; 2016 Sep; 65(9):1456-62. PubMed ID: 26585938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice.
    Negi S; Saini S; Tandel N; Sahu K; Mishra RPN; Tyagi RK
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous hematopoietic stem cells for refractory Crohn's disease.
    DiNicola CA; Zand A; Hommes DW
    Expert Opin Biol Ther; 2017 May; 17(5):555-564. PubMed ID: 28326848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD.
    Ricart E
    Dig Dis; 2012; 30(4):387-91. PubMed ID: 22796802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell-Based Therapies for Inflammatory Bowel Disease.
    Zhang HM; Yuan S; Meng H; Hou XT; Li J; Xue JC; Li Y; Wang Q; Nan JX; Jin XJ; Zhang QG
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.